Inhaled antibody therapy shows promise for COVID-19 treatment

The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

Will the MAHA movement include alcohol among its targets?

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning! There are just two days

January 14, 2025

Arrowhead reports full Phase 2b data for lipid drug, but Ionis is a step ahead: #ACC24

Five months after Arrowhead Pharmaceuticals unveiled topline results for its Phase 2b RNAi candidate in a lipid-related disease, the company on Sunday reported full data

April 8, 2024

A big week for rats, genetics of picky eating, and research misconduct rules

If you’re a health care worker who vibes with this Tiktok, have I got a newsletter for you: STAT’s Health Care, Inc. by Bob Herman

September 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.